Found 16 matching trials
A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) PHASE2 The purpose of this trial is to investigate the safety and tolerability of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis EARLY_PHASE1 To evaluate if transcranial magnetic stimulation can be used as a biomarker...
Show More Learn More & Join Trial
Post-stroke Epilepsy: Primary Prophylaxis Study NA Advance in stroke treatment have resulted in a dramatic reduction in the st...
Show More Location
National Cheng Kung University Hospital
Learn More & Join Trial
Bioequivalence Assessment Between Two Perampanel Oral Suspension Formulations PHASE1 An open label, randomized, single-dose, two-sequences, two-periods, crossov...
Show More Location
Advanced Research Center (ARC)
Learn More & Join Trial
Perampanel in Focal Status Epilepticus PHASE3 Randomized controlled trial on focal motor status epilepticus (SE), studyin...
Show More Location
Urgences, CHU Lille (Hôpital Roger Salengro)
Learn More & Join Trial
A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures N/A The primary purpose of this study is to investigate the effectiveness refle...
Show More Location
Eisai Trial Site #51
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy N/A The purpose of the study is to evaluate the safety and efficacy of Fycompa®...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus PHASE4 This project is aiming to better understand the use of perampanel as an app...
Show More Location
Wayne State University
Learn More & Join Trial
An Extended Access Program for Perampanel N/A The Extended Access Program (EAP) is a managed access programme for Perampa...
Show More Status
No Longer Available
Location
Fundacion Cerebro Y Mente
Learn More & Join Trial
Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects PHASE1 This study will be conducted to evaluate the bioavailability of a single 12...
Show More Location
Anaheim Clinical Trials
Learn More & Join Trial